M J Camarasa - JoVE Visualize

Showing results (41-50 of 53) with videos related to

Pageof 6

Sort By:

Antiviral Research|June 9, 2001

Exploring the role of the 5'-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivativesC Chamorro, M J Pérez-Pérez, F Rodríguez-Barrios, et al.

Journal of Medicinal Chemistry|November 25, 1994

1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activityR Alvarez, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|January 1, 1985

Uridine 5'-diphosphate glucose analogues. Inhibitors of protein glycosylation that show antiviral activityM J Camarasa, P Fernández-Resa, M T Garcia-López, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992

2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptaseJ Balzarini, M J Pérez-Pérez, A San-Félix, et al.

Revista Espanola De Oncologia|January 1, 1982

[Synthesis, cytostatic activity and mechanism of action of N-glycosylhalomethylazoles. A new class of alkylating agents]G Alonso, R Alonso, M J Camarasa, et al.

Virology|January 1, 1993

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptaseJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.

Journal of Virology|June 8, 2001

Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIVJ Balzarini, M J Camarasa, M J Pérez-Pérez, et al.

Nucleosides & Nucleotides|August 5, 1999

Novel TSAO derivatives modified at positions 3" and 4" of the spiro moietyE Lobatón, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|June 1, 2001

Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptaseF Rodríguez-Barrios, C Pérez, E Lobatón, et al.

Virology|February 13, 2001

Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138H Pelemans, A Aertsen, K Van Laethem, et al.

Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:

Pageof 6

Antiviral Research|June 9, 2001

Exploring the role of the 5'-position of TSAO-T. Synthesis and anti-HIV evaluation of novel TSAO-T derivativesC Chamorro, M J Pérez-Pérez, F Rodríguez-Barrios, et al.

Journal of Medicinal Chemistry|November 25, 1994

1,2,3-Triazole-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D- ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"-oxathiole 2",2"-dioxide) (TSAO) analogues: synthesis and anti-HIV-1 activityR Alvarez, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|January 1, 1985

Uridine 5'-diphosphate glucose analogues. Inhibitors of protein glycosylation that show antiviral activityM J Camarasa, P Fernández-Resa, M T Garcia-López, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992

2',5'-Bis-O-(tert-butyldimethylsilyl)-3'-spiro-5''-(4''-amino-1'',2''- oxathiole-2'',2'-dioxide)pyrimidine (TSAO) nucleoside analogues: highlyselective inhibitors of human immunodeficiency virus type 1 that are targeted at the viral reverse transcriptaseJ Balzarini, M J Pérez-Pérez, A San-Félix, et al.

Revista Espanola De Oncologia|January 1, 1982

[Synthesis, cytostatic activity and mechanism of action of N-glycosylhalomethylazoles. A new class of alkylating agents]G Alonso, R Alonso, M J Camarasa, et al.

Virology|January 1, 1993

HIV-1-specific reverse transcriptase inhibitors show differential activity against HIV-1 mutant strains containing different amino acid substitutions in the reverse transcriptaseJ Balzarini, A Karlsson, M J Pérez-Pérez, et al.

Journal of Virology|June 8, 2001

Exploitation of the low fidelity of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and the nucleotide composition bias in the HIV-1 genome to alter the drug resistance development of HIVJ Balzarini, M J Camarasa, M J Pérez-Pérez, et al.

Nucleosides & Nucleotides|August 5, 1999

Novel TSAO derivatives modified at positions 3" and 4" of the spiro moietyE Lobatón, S Velázquez, A San-Félix, et al.

Journal of Medicinal Chemistry|June 1, 2001

Identification of a putative binding site for [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide)thymine (TSAO) derivatives at the p51-p66 interface of HIV-1 reverse transcriptaseF Rodríguez-Barrios, C Pérez, E Lobatón, et al.

Virology|February 13, 2001

Site-directed mutagenesis of human immunodeficiency virus type 1 reverse transcriptase at amino acid position 138H Pelemans, A Aertsen, K Van Laethem, et al.

Pageof 6